No Picture
News

Debut Raises $34M in Series B Funding Led by L’Oréal To Create the Next Generation of High-Performing Active Ingredients

The partnership with BOLD, L’Oréal’s venture capital fund, will enable Debut to bring novel bioactive cosmetic ingredients and products to consumers worldwide SAN DIEGO, June 1, 2023 /PRNewswire/ –?Debut, a vertically integrated synthetic biology company […]

No Picture
News

Navigate BioPharma Services, Inc. launches new multiplex digital PCR assay for comprehensive quantification of up to 5 different CAR-T transgenes

CARLSBAD, Calif., June 1, 2023 /PRNewswire/ — During this year’s AAPS National biotechnology conference, Navigate BioPharma Services, Inc., a Novartis subsidiary and a leading provider of innovative biomarker solutions for drug development, announced the launch […]

No Picture
News

Bayer buys license to Cedilla preclinical cancer program; MEI Pharma says no to unsolicited offer

Bayer has acquired exclusive rights to Cedilla Therapeutics’ preclinical cancer drug candidates for an undisclosed amount. Bayer announced Thursday morning that it is acquiring the license for Cedilla’s preclinical Cyclin E1/CDK2 complex inhibitors. Cyclin E1 […]

No Picture
News

Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will present […]